Zimmer Biomet Holdings Price to Sales Ratio 2010-2025 | ZBH
Historical PS ratio values for Zimmer Biomet Holdings (ZBH) over the last 10 years. The current P/S ratio for Zimmer Biomet Holdings as of July 04, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Zimmer Biomet Holdings P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-07-03 | 93.67 | 2.47 | |
| 2025-03-31 | 112.89 | $37.88 | 2.98 |
| 2024-12-31 | 105.13 | $37.48 | 2.81 |
| 2024-09-30 | 107.20 | $36.81 | 2.91 |
| 2024-06-30 | 107.54 | $36.17 | 2.97 |
| 2024-03-31 | 130.48 | $35.67 | 3.66 |
| 2023-12-31 | 120.09 | $35.21 | 3.41 |
| 2023-09-30 | 110.52 | $34.64 | 3.19 |
| 2023-06-30 | 143.08 | $34.23 | 4.18 |
| 2023-03-31 | 126.75 | $33.79 | 3.75 |
| 2022-12-31 | 124.85 | $33.01 | 3.78 |
| 2022-09-30 | 102.18 | $32.78 | 3.12 |
| 2022-06-30 | 102.45 | $32.84 | 3.12 |
| 2022-03-31 | 124.44 | $32.73 | 3.80 |
| 2021-12-31 | 119.68 | $32.44 | 3.69 |
| 2021-09-30 | 137.62 | $29.73 | 4.63 |
| 2021-06-30 | 150.98 | $30.98 | 4.87 |
| 2021-03-31 | 150.06 | $28.54 | 5.26 |
| 2020-12-31 | 144.23 | $29.56 | 4.88 |
| 2020-09-30 | 127.22 | $34.10 | 3.73 |
| 2020-06-30 | 111.35 | $33.99 | 3.28 |
| 2020-03-31 | 94.10 | $37.71 | 2.50 |
| 2019-12-31 | 138.99 | $38.67 | 3.59 |
| 2019-09-30 | 127.27 | $38.56 | 3.30 |
| 2019-06-30 | 108.97 | $38.36 | 2.84 |
| 2019-03-31 | 117.94 | $38.53 | 3.06 |
| 2018-12-31 | 95.61 | $38.79 | 2.46 |
| 2018-09-30 | 120.90 | $38.77 | 3.12 |
| 2018-06-30 | 102.30 | $38.71 | 2.64 |
| 2018-03-31 | 99.87 | $38.47 | 2.60 |
| 2017-12-31 | 110.28 | $38.32 | 2.88 |
| 2017-09-30 | 106.80 | $38.04 | 2.81 |
| 2017-06-30 | 116.87 | $38.18 | 3.06 |
| 2017-03-31 | 110.93 | $38.31 | 2.90 |
| 2016-12-31 | 93.57 | $38.02 | 2.46 |
| 2016-09-30 | 117.61 | $38.34 | 3.07 |
| 2016-06-30 | 108.68 | $37.87 | 2.87 |
| 2016-03-31 | 96.07 | $34.92 | 2.75 |
| 2015-12-31 | 92.22 | $32.06 | 2.88 |
| 2015-09-30 | 84.25 | $29.00 | 2.91 |
| 2015-06-30 | 97.75 | $26.87 | 3.64 |
| 2015-03-31 | 104.96 | $27.04 | 3.88 |
| 2014-12-31 | 101.11 | $27.24 | 3.71 |
| 2014-09-30 | 89.46 | $27.34 | 3.27 |
| 2014-06-30 | 92.21 | $27.14 | 3.40 |
| 2014-03-31 | 83.79 | $27.07 | 3.10 |
| 2013-12-31 | 82.37 | $26.98 | 3.05 |
| 2013-09-30 | 72.45 | $26.47 | 2.74 |
| 2013-06-30 | 65.94 | $26.08 | 2.53 |
| 2013-03-31 | 66.01 | $25.61 | 2.58 |
| 2012-12-31 | 58.33 | $25.33 | 2.30 |
| 2012-09-30 | 59.02 | $24.81 | 2.38 |
| 2012-06-30 | 56.02 | $24.42 | 2.29 |
| 2012-03-31 | 55.79 | $23.94 | 2.33 |
| 2011-12-31 | 46.23 | $23.31 | 1.98 |
| 2011-09-30 | 46.29 | $22.76 | 2.03 |
| 2011-06-30 | 54.70 | $22.13 | 2.47 |
| 2011-03-31 | 52.39 | $21.44 | 2.44 |
| 2010-12-31 | 46.46 | $20.89 | 2.22 |
| 2010-09-30 | 45.29 | $20.38 | 2.22 |
| 2010-06-30 | 46.78 | $20.09 | 2.33 |
| 2010-03-31 | 51.24 | $19.62 | 2.61 |
| 2009-12-31 | 51.16 | $18.88 | 2.71 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.532B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
| Boston Scientific (BSX) | United States | $154.336B | 38.64 |
| Stryker (SYK) | United States | $150.874B | 31.55 |
| EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
| Medtronic (MDT) | Ireland | $113.364B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
| ResMed (RMD) | United States | $37.677B | 28.30 |
| GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
| Agilent Technologies (A) | United States | $34.480B | 22.48 |
| Terumo (TRUMY) | Japan | $25.244B | 32.79 |
| Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
| Insulet (PODD) | United States | $21.186B | 83.16 |
| Baxter (BAX) | United States | $15.914B | 11.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.846B | 23.82 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.952B | 17.66 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.693B | 16.82 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.456B | 28.72 |
| ICU Medical (ICUI) | United States | $3.333B | 24.58 |
| QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.907B | 42.62 |
| AtriCure (ATRC) | United States | $1.572B | 0.00 |
| Acuren (TIC) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
| Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
| Neogen (NEOG) | United States | $1.157B | 14.81 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.085B | 0.00 |
| InMode (INMD) | Israel | $0.958B | 9.66 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Owens & Minor (OMI) | United States | $0.712B | 5.90 |
| CeriBell (CBLL) | United States | $0.684B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| Quanterix (QTRX) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| ZimVie (ZIMV) | United States | $0.285B | 12.98 |
| Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
| Brainsway (BWAY) | Israel | $0.250B | 66.20 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.231B | 6.49 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.48 |
| MacroGenics (MGNX) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.86 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |